Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 25:13:273.
doi: 10.3389/fncel.2019.00273. eCollection 2019.

Combined Cyclosporin A and Hypothermia Treatment Inhibits Activation of BV-2 Microglia but Induces an Inflammatory Response in an Ischemia/Reperfusion Hippocampal Slice Culture Model

Affiliations

Combined Cyclosporin A and Hypothermia Treatment Inhibits Activation of BV-2 Microglia but Induces an Inflammatory Response in an Ischemia/Reperfusion Hippocampal Slice Culture Model

Sylvia J Wowro et al. Front Cell Neurosci. .

Abstract

Introduction: Hypothermia attenuates cerebral ischemia-induced neuronal cell death associated with neuroinflammation. The calcineurin inhibitor cyclosporin A (CsA) has been shown to be neuroprotective by minimizing activation of inflammatory pathways. Therefore, we investigated whether the combination of hypothermia and treatment with CsA has neuroprotective effects in an oxygen-glucose deprivation/reperfusion (OGD/R) injury model in neuronal and BV-2 microglia monocultures, as well as in an organotypic hippocampal slice culture (OHSC).

Methods: Murine primary neurons, BV-2 microglia, and OHSC were pretreated with CsA and exposed to 1 h OGD (0.2% O2) followed by reperfusion at normothermia (37°C) or hypothermia (33.5°C). Cytotoxicity was measured by lactate dehydrogenase and glutamate releases. Damage-associated molecular patterns (DAMPs) high mobility group box 1 (HMGB1), heat shock protein 70 (Hsp70), and cold-inducible RNA-binding protein (CIRBP) were detected in cultured supernatant by western blot analysis. Interleukin-6 (IL-6), Interleukin-1α and -1β (IL-1α/IL1-β), tumor necrosis factor-α (TNF-α), monocyte chemotactic protein 1 (MCP1), inducible nitric oxide synthase (iNOS), glia activation factors ionized calcium-binding adapter molecule 1 (Iba1), and transforming growth factor β1 (TGF-β1) gene expressions were analyzed by RT-qPCR.

Results: Exposure to OGD plus 10 μM CsA was sufficient to induce necrotic cell death and subsequent release of DAMPs in neurons but not BV-2 microglia. Moreover, OGD/R-induced secondary injury was also observed only in the neurons, which was not attenuated by cooling and no increased toxicity by CsA was observed. BV-2 microglia were not sensitive to OGD/R-induced injury but were susceptible to CsA-induced toxicity in a dose dependent manner, which was minimized by hypothermia. CsA attenuated IL-1β and Iba1 expressions in BV-2 microglia exposed to OGD/R. Hypothermia reduced IL-1β and iNOS expressions but induced TNF-α and Iba1 expressions in the microglia. However, these observations did not translate to the ex vivo OHCS model, as general high expressions of most cytokines investigated were observed.

Conclusion: Treatment with CsA has neurotoxic effects on primary neurons exposed to OGD but could inhibit BV-2 microglia activation. However, CsA and hypothermia treatment after ischemia/reperfusion injury results in cytotoxic neuroinflammation in the complex ex vivo OHSC.

Keywords: BV-2 microglia; DAMPs; cyclosporin A; hypothermia; inflammation; organotypic hippocampal slice culture; oxygen-glucose deprivation/reperfusion; primary neuron.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Experimental time-temperature protocol. Cyclosporin A (CsA) was applied 1 h before the simulated ischemia phase by oxygen-glucose-deprivation (OGD at 0.2% O2 in glucose-depleted medium) and maintained after the reperfusion phase for the duration of experiment. Exposure to OGD for 1 h was performed at 37°C, followed by reperfusion (OGD/R) for 24 h at 37°C (normothermia) or 33.5°C (hypothermia).
FIGURE 2
FIGURE 2
Lactate dehydrogenase releases were measured from primary neurons (A) and BV-2 microglia cells (B) in the experimental control group exposed to 1 h normoxia (21% O2 in glucose-containing medium) and simulated ischemia group exposed to 1 h oxygen-glucose deprivation (OGD at 0.2% O2 in glucose-depleted medium) at 37°C, and also after reperfusion from primary neurons (C) and BV-2 microglia cells (D) exposed to 1 h normoxia + 24 h reperfusion with complete medium (Normoxia/R) or 1 h OGD + 24 h reperfusion (OGD/R) at either 37 or 33.5°C. All CsA groups were pre-treated 1 h before experimental start with either 1 or 10 μM CsA at 37°C. Data from 4 to 6 individual experiments are presented as box-and-whiskers plot (box from 25th to 75th percentile and whisker min to max). Statistical analysis were conducted using one-way ANOVA followed by the Tukey post hoc test; ∗∗p < 0.01, ∗∗∗p < 0.001 compared to Normoxia at 37°C, and #p < 0.05 for group comparison were considered significant.
FIGURE 3
FIGURE 3
(A) LDH and (B) glutamate releases from OHSCs were assessed from the cultured supernatants of the experimental control group exposed to 1 h normoxia (21% O2 in glucose-containing medium) and simulated ischemia group exposed to 1 h oxygen-glucose deprivation (OGD at 0.2% O2 in glucose-depleted medium) at 37°C. All CsA containing groups were pre-treated 1 h before experimental start with 10 μM CsA at 37°C. Data from 4 to 5 individual experiments are presented as box-and-whiskers plot (box from 25th to 75th percentile and whisker min to max). Statistical analysis were conducted using one-way ANOVA followed by the Tukey post hoc test; ∗∗p < 0.01, ∗∗∗p < 0.001 compared to Normoxia at 37°C, and #p < 0.05 for group comparison were considered significant.
FIGURE 4
FIGURE 4
Propidium iodide (PI) staining; OHSCs in the experimental control group (Normoxia/R) were exposed to 1 h normoxia (21% O2 in glucose-containing medium) + 24 h reperfusion (21% O2 in glucose-containing medium) and simulated ischemia groups were exposed to 1 h oxygen-glucose deprivation (OGD at 0.2% O2 in glucose-depleted medium) + 24 h reperfusion (OGD/R at 21% O2 in glucose-containing medium) at either 37 or 33.5°C. All cyclosporin A (CsA) containing groups were pre-treated 1 h before experimental start with 10 μM CsA at 37°C and maintained throughout the duration of the experiment. Images are shown at 40× magnification. CA, Cornu Ammonis; DG, Dentate Gyrus.
FIGURE 5
FIGURE 5
Western Blot analysis was used to assess extracellular DAMPs, (A,D) heat shock protein 70 (Hsp70), (B,E) high mobility group box 1 (HMGB1), and (C) cold-inducible RNA-binding protein (CIRBP) released into the cultured supernatant from primary neurons and BV-2 microglial cells. The experimental control group was exposed to 1 h normoxia (21% O2 in glucose-containing medium) and simulated ischemia group was exposed to 1 h oxygen-glucose deprivation (OGD at 0.2% O2 in glucose-depleted medium) at 37°C. Quantitative densitometric analysis from 5 to 6 individual experiments is presented as box-and-whiskers plot (box from 25th to 75th percentile and whisker min to max), along with the representative immunoblots. Statistical analysis were conducted using one-way ANOVA followed by the Tukey post hoc test; ∗∗p < 0.01, ∗∗∗p < 0.001 compared to normoxia at 37°C, and #p < 0.05 for group comparison were considered significant.
FIGURE 6
FIGURE 6
RT-qPCR was used to assess gene expressions in BV-2 microglia, OHSCs, and primary neurons for inflammatory (A,E,I) IL-6, (B,F) TNF-α, (C,G) IL-1β, and (D,H) IL-1α after exposure to Normoxia/R (1 h normoxia + 24 h reperfusion at 21% O2 in glucose-containing medium) or OGD/R (1 h OGD + 24 h reperfusion at 0.2% O2 in glucose-depleted medium) at either 37 or 33.5°C. All CsA containing groups were pre-treated with 10 μM CsA at 37°C. Data from 4 to 5 individual experiments are presented as box-and-whiskers plot (box from 25th to 75th percentile and whisker min to max). Statistical analysis were conducted using one-way ANOVA followed by the Tukey post hoc test; p < 0.01, ∗∗p < 0.01, ∗∗∗p < 0.001 compared to Normoxia/R at 37°C, and #p < 0.05 for group comparison were considered significant.
FIGURE 7
FIGURE 7
RT-qPCR was used to assess gene expressions in the BV-2 microglia, OHSCs, and primary neurons for (A,E,I) MCP1, (B,F) Iba1, (C,G) TGF-β1, and (D,H) iNOS after exposure to Normoxia/R (1 h normoxia + 24 h reperfusion at 21% O2 in glucose-containing medium) or OGD/R (1 h OGD + 24 h reperfusion at 0.2% O2 in glucose-depleted medium) at either 37 or 33.5°C. All CsA containing groups were pre-treated with 10 μM CsA at 37°C. Data from 4 to 5 individual experiments are presented as box-and-whiskers plot (box from 25th to 75th percentile and whisker min to max). Statistical analysis were conducted using one-way ANOVA followed by the Tukey post hoc test; p < 0.01, ∗∗p < 0.01, ∗∗∗p < 0.001 compared to Normoxia/R at 37°C, and #p < 0.05 for group comparison were considered significant.

Similar articles

Cited by

References

    1. Amantea D., Nappi G., Bernardi G., Bagetta G., Corasaniti M. T. (2009). Post-ischemic brain damage: pathophysiology and role of inflammatory mediators. FEBS J. 276 13–26. 10.1111/j.1742-4658.2008.06766.x - DOI - PubMed
    1. Andersson U., Tracey K. J. (2011). HMGB1 is a therapeutic target for sterile inflammation and infection. Annu. Rev. Immunol. 29 139–162. 10.1146/annurev-immunol-030409-101323 - DOI - PMC - PubMed
    1. Asea A., Kraeft S. K., Kurt-Jones E. A., Stevenson M. A., Chen L. B., Finberg R. W., et al. (2000). HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat. Med. 6 435–442. 10.1038/74697 - DOI - PubMed
    1. Azzopardi D., Strohm B., Marlow N., Brocklehurst P., Deierl A., Eddama O., et al. (2014). Effects of hypothermia for perinatal asphyxia on childhood outcomes. N. Engl. J. Med. 371 140–149. 10.1056/NEJMoa1315788 - DOI - PubMed
    1. Becerra-Calixto A., Cardona-Gomez G. P. (2017). The role of astrocytes in neuroprotection after brain stroke: potential in cell therapy. Front. Mol. Neurosci. 10:88 10.3389/fnmol.2017.00088 - DOI - PMC - PubMed